Related Experiment Video
Updated: May 29, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
The timing, extent, progression and regression of deep vein thrombosis in immobile stroke patients: observational
1Division of Clinical Neurosciences, Western General Hospital, University of Edinburgh, Edinburgh, UK. martin.dennis@ed.ac.uk
Insights
Deep vein thrombosis (DVT) in stroke patients is common, with over 14% developing it. Prophylaxis for deep vein thrombosis should be initiated early and maintained for at least four weeks.
Area of Science:
- Neurology
- Vascular Medicine
- Medical Imaging
Background:
- Deep vein thrombosis (DVT) is a significant complication following stroke.
- Evidence supporting prophylactic strategies for DVT in stroke patients is often conflicting.
Purpose of the Study:
- To determine the incidence and extent of DVT in immobile stroke patients.
- To identify clinical features associated with DVT post-stroke.
- To describe the natural evolution of DVT in this population.
Main Methods:
- Utilized data from the CLOTS trials 1 and 2, involving 5632 immobile stroke patients across 135 hospitals in nine countries.
- Employed compression duplex ultrasound (CDU) for screening asymptomatic DVT at approximately 7-10 days and 25-30 days post-enrollment.
Main Results:
- A total of 11.4% of patients developed DVT within the first week, with an additional 3.1% developing it by day 28.
- Of DVTs detected, 35% were symptomatic, and 5% were associated with pulmonary embolism (PE).
- DVT distribution varied, with 39% limited to calf veins and 40% involving femoral veins; 47% of early DVTs regressed, 44% remained stable, and 9% progressed.
Conclusions:
- Deep vein thrombosis in stroke patients can manifest both early and late, with some cases progressing over time.
- Current prophylactic strategies for DVT require early initiation.
- Prophylaxis for deep vein thrombosis should ideally extend for a minimum of four weeks to address the evolving risk.
Background:
Deep vein thrombosis (DVT) is an important complication of stroke, but the evidence to support commonly used prophylactic strategies is conflicting.
Objectives:
To describe the incidence, extent, associated clinical features and evolution of DVT after stroke.
Patients/Methods:
The CLOTS trials 1 and 2 together randomized 5632 immobile stroke patients in 135 hospitals in nine countries. We screened patients for asymptomatic DVT with compression duplex ultrasound (CDU) at about 7-10 days and again at about 25-30 days after enrollment.
Results:
Six hundred and forty-one (11.4%) of 5632 patients had DVT detected on the first CDU scan at a median of 8 days (interquartile range [IQR] 7-10 days) after enrollment, and an additional 176 (3.1%) had a DVT on the second CDU scan at a median of 28 days (IQR 26-30 days). Of the 817 with DVTs, 289 (35%) were symptomatic and 39 (5%) had pulmonary embolism (PE) confirmed by imaging. Six hundred and seventy-six (83%) were unilateral, 141 (17%) were bilateral, 322 (39%) were limited to calf veins, 172 (21%) were popliteal, and 323 (40%) were femoral. Among the 542 patients with DVT and a weak leg, the DVT affected the weaker leg in 396 (73%), the stronger leg in 59 (11%), and was bilateral in 87 (16%). Among the 318 patients with a DVT detected on the first CDU scan who had a second scan, the DVT regressed in 148 (47%), stayed the same in 140 (44%), and progressed in only 30 (9%).
Conclusions:
Although most DVTs develop within the first week, some develop later, and some early DVTs progress. Any prophylaxis needs to be started early but ideally continued for at least 4 weeks.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism III: Nursing Management
Ischemic Stroke ll: Pathophysiology
